ArticlePloS one2022

Comparison of risks of arterial thromboembolic events and glaucoma with ranibizumab and aflibercept intravitreous injection: A nationwide population-based cohort study.

Yin-Hsi Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.